New Laws Limiting Opioid Prescriptions Create Undue Barriers for Patients With Cancer and Cancer Survivors
ASCO POST (September 25, 2018)
9 Pages Posted: 5 Nov 2018
Date Written: September 25, 2018
Among other policy responses to the growing opioid epidemic, many states have enacted legislation that limits the duration or amount of opioid prescriptions issued by physicians. Although, it is clear we need strong measures to mitigate widespread overuse and misuse of opioids. These prescription-limit laws unnecessarily sweep too broadly, intruding on clinician discretion and unduly restricting the pain management of patients with cancer and cancer survivors with a legitimate medical need for opioids.
In response to this problem, several medical societies, including ASCO, and individual commentators have called on lawmakers to recalibrate the balance between reducing misuse while still enabling appropriate access. Here, we explain how prescription-limit laws adversely affect patients with cancer and cancer survivors.
Note: “Reprinted from The ASCO Post, with permission from Harborside. © 2018.”
Keywords: opioid, cancer, oncology
JEL Classification: I18, K32
Suggested Citation: Suggested Citation